The Agilent Thermal Equilibration Device Increases Resolution for Oligonucleotide Analysis

Application Note Biopharma/Pharma Analyzing Raw Material for Oligonucleotide Synthesis Flexible and robust method development for the analysis of nucleoside phosphoramidites with the Agilent 1290 Infinity II Bio LC System 100 Response (mAU) 80 60 40 20 0 0 5 10…

Application Note Biopharma/Pharma Peptide Mapping at Elevated Temperatures Response Method Development with the Agilent 1290 Infinity II Bio LC System and Agilent Thermal Equilibration Device Author Adem Cakar Agilent Technologies, Inc. 2.8 2.7 2.6 2.5 2.4 2.3 2.2 2.1 2.0…

Agilent InfinityLab Bio LC Solutions High-Performance Biopharma Analysis Application compendium 2 Overcome Analytical Challenges in Biopharma The growing complexity of biopharma analysis calls for innovation that delivers excellence across the biopharmaceutical workflow. The Agilent InfinityLab Bio LC Solutions comprise a…

Image © Agilent Technologies, Inc. 2024 Sponsored by Driving the Field of Oligonucleotide Therapeutics State-of-the-Art Solutions for Oligonucleotide Characterization, Purification, and Manufacturing / Chapter 1: Introduction to Oligonucleotide Therapeutics / Chapter 2: Challenges for Oligonucleotide Synthesis and Production / Chapter…